Management's Plans for Continuing Operations (Details Textuals) (USD $)	2 Months Ended	3 Months Ended				9 Months Ended
	Nov. 17, 2013	Sep. 28, 2013	Jun. 29, 2013	Mar. 30, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012
Management's Plans for Continuing Operations
Net loss		$ (1,250,263)	$ (1,020,866)	$ (1,424,072)	$ (1,538,034)	$ (3,695,201)	$ (9,963,844)
Operating loss		(1,241,773)			(1,531,638)	(3,671,359)	(9,943,877)
Share based compensation expense						1,059,653
Patent expense						276,362
Operating loss from BluScience						192,399
Shares of stock sold	3,529,411
Shares of stock sold, selling price per share	$ 0.85
Gross proceeds from sale of stock	3,000,000
Net proceeds from sale of stock	$ 2,980,000